EA201070817A1 - ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ - Google Patents

ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ

Info

Publication number
EA201070817A1
EA201070817A1 EA201070817A EA201070817A EA201070817A1 EA 201070817 A1 EA201070817 A1 EA 201070817A1 EA 201070817 A EA201070817 A EA 201070817A EA 201070817 A EA201070817 A EA 201070817A EA 201070817 A1 EA201070817 A1 EA 201070817A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
alkyl
alkoxy
atom
hydrogen atom
Prior art date
Application number
EA201070817A
Other languages
English (en)
Inventor
Жан-Франсуа Пэронель
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201070817(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA201070817A1 publication Critical patent/EA201070817A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Соединения формулы (I), в которой Х и Y вместе с атомом азота, с которым они связаны, образуют 5-10-звенный моно- или бициклический амин, насыщенный или частично насыщенный, возможно содержащий 1-2 дополнительных гетероатома, выбранных из О, S, N, возможно замещенный атомом галогена, (C-С)алкильной группой, (C-C)алкоксигруппой, циано, NRaRb, COOR, (C-С)алкильной и (C-C)алкоксигруппами, возможно замещенными одним или несколькими атомами галогена; Rозначает атом водорода, атом галогена, (C-С)алкоксигруппу, (C-С)алкильную группу; Rозначает атом водорода, (C-С)алкильную группу, возможно замещенную; (C-С)алкоксигруппу, возможно замещенную; (С-С)алкенильную группу, (С-С)алкинильную группу, группу -CO-R, группу -CO-NRR, группу -CO-O-R, группу -NR-СО-R, группу -N=CH-NRaRb, атом галогена, группу циано, нитро, гидроксииминоалкильную, алкоксииминоалкильную группу, (C-С)алкилтиогруппу, (C-С)алкилсульфинильную группу, (C-С)алкилсульфонильную группу, (((C-C)алкил))силилэтинильную группу, группу -SO-NRR, фенильную группу, возможно замещенную, гетероциклическую группу, возможно замещенную; Rозначает атом водорода, (С-С)алкильную группу, (C-С)алкоксигруппу или атом галогена, Rозначает атом водорода, (C-C)алкильную группу, (C-C)алкоксигруппу или атом фтора, в состоянии основания или кислотно-аддитивной соли. Применение в терапии.
EA201070817A 2008-01-02 2008-12-31 ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ EA201070817A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800004A FR2925902B1 (fr) 2008-01-02 2008-01-02 DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001835 WO2009112651A1 (fr) 2008-01-02 2008-12-31 Dérivés d'mtoazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
EA201070817A1 true EA201070817A1 (ru) 2011-02-28

Family

ID=39739369

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070817A EA201070817A1 (ru) 2008-01-02 2008-12-31 ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ

Country Status (21)

Country Link
US (1) US20100317656A1 (ru)
EP (1) EP2225244A1 (ru)
JP (1) JP2011508759A (ru)
KR (1) KR20100109941A (ru)
CN (1) CN101959886A (ru)
AR (1) AR070073A1 (ru)
AU (1) AU2008352728A1 (ru)
BR (1) BRPI0822223A2 (ru)
CA (1) CA2710797A1 (ru)
CL (1) CL2008003927A1 (ru)
CO (1) CO6331307A2 (ru)
EA (1) EA201070817A1 (ru)
FR (1) FR2925902B1 (ru)
IL (1) IL206673A0 (ru)
MA (1) MA32057B1 (ru)
MX (1) MX2010007351A (ru)
PA (1) PA8810101A1 (ru)
PE (1) PE20091182A1 (ru)
TW (1) TW200932746A (ru)
UY (1) UY31588A1 (ru)
WO (1) WO2009112651A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2012026766A2 (ko) * 2010-08-25 2012-03-01 (주)네오팜 신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
US9981944B2 (en) 2015-02-20 2018-05-29 Rigel Pharmaceuticals, Inc GDF-8 inhibitors
RU2764243C2 (ru) 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
CA3076476A1 (en) 2017-10-18 2019-04-25 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
CA3080677A1 (en) 2017-11-06 2019-05-09 Jubilant Prodel LLC Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation
CN107915752B (zh) * 2017-11-14 2018-09-18 牡丹江医学院 一种治疗白内障的药物及其制备方法
EP3704120B1 (en) 2017-11-24 2024-03-06 Jubilant Episcribe LLC Heterocyclic compounds as prmt5 inhibitors
CN112105610B (zh) 2018-03-13 2024-01-26 朱比连特普罗德尔有限责任公司 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827189D0 (en) * 1988-11-21 1988-12-29 Fujisawa Pharmaceutical Co 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same
US5716964A (en) * 1989-12-04 1998-02-10 G.D. Searle & Co. Tetrazolyl substituted imidazo 1,2-a!pyridinylalkyl compounds for treatment of neurotoxic injury
FR2696177B1 (fr) * 1992-09-28 1995-05-12 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
GB0420519D0 (en) * 2004-09-15 2004-10-20 Novartis Ag Organic compounds
EP2187883A2 (en) * 2007-08-10 2010-05-26 Genelabs Technologies, Inc. Nitrogen containing bicyclic chemical entities for treating viral infections
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Also Published As

Publication number Publication date
CN101959886A (zh) 2011-01-26
UY31588A1 (es) 2009-08-03
CL2008003927A1 (es) 2010-02-12
MA32057B1 (fr) 2011-02-01
WO2009112651A1 (fr) 2009-09-17
AR070073A1 (es) 2010-03-10
MX2010007351A (es) 2010-10-05
US20100317656A1 (en) 2010-12-16
PA8810101A1 (es) 2009-08-26
KR20100109941A (ko) 2010-10-11
BRPI0822223A2 (pt) 2015-06-23
PE20091182A1 (es) 2009-08-31
JP2011508759A (ja) 2011-03-17
TW200932746A (en) 2009-08-01
AU2008352728A1 (en) 2009-09-17
CA2710797A1 (fr) 2009-09-17
EP2225244A1 (fr) 2010-09-08
FR2925902B1 (fr) 2011-01-07
FR2925902A1 (fr) 2009-07-03
IL206673A0 (en) 2010-12-30
CO6331307A2 (es) 2011-10-20

Similar Documents

Publication Publication Date Title
EA201070817A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
EA201071111A1 (ru) ПОЛИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 6-ГЕТЕРОАРИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
PE20090596A1 (es) Imidazoles biciclicos fusionados
PE20091712A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
RS53939B1 (en) 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR APPLICATIONS AS ANTAGONISTS OF ADENOSIN A2A RECEPTOR
EA200970656A1 (ru) Вич-ингибирующие 5,6-замещенные пиримидины
EA201071113A1 (ru) ПОЛИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2-ГЕТЕРОАРИЛ-6-ФЕНИЛИМИДАЗО[1,2-α] ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
PE20151249A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
PE20090511A1 (es) Imidazopiridinonas
PE20121506A1 (es) Compuestos triazolopiridinas como inhibidores de c-met
AR048069A1 (es) Derivados de pirazolo con heteroarilo fusionado
EA201171386A1 (ru) ПРОИЗВОДНЫЕ ЦИКЛОПЕНТА[c]ПИРРОЛ-2-КАРБОКСИЛАТОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
MY145603A (en) 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
PE20100737A1 (es) Nuevos compuestos
PE20141050A1 (es) Inhibidores de quinasa relacionados con pirrolo (2,3-d) pirimidina tropomiosina
PE20110582A1 (es) Arilciclohexileteres de dihidro-tetraazabenzoazuleno
EA201170237A1 (ru) Производные карбаматов алкилтиазолов, их получение и их применение в терапии
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
PE20081159A1 (es) Inhibidores de las quinasas y metodos para su utilizacion
EA201171000A1 (ru) Производные азаспиранилалкилкарбаматов в форме 5-членных гетероциклов, способ их получения и применение в терапии
PE20060600A1 (es) Derivados de aminopiridina como inhibidores selectivos de la aurora a quinasa
EA201170099A1 (ru) Замещенные пиримидин-4-оновые производные
HRP20040429B1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa